Brief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
22/12/2022 12:44
Dec 22 (Reuters) - Tetra Bio Pharma Inc TBP.TO :
* ON DECEMBER 21, RECEIVED A SECOND CLARIFAX FROM HEALTH
CANADA
REGARDING REDUVO RISK MANAGEMENT PLAN
Source text for Eikon: ID:nCNWzSbf1a
Further company coverage: TBP.TO
((Reuters.Briefs@thomsonreuters.com))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding